Utah Retirement Systems’s Integra LifeSciences IART Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-3,900
Closed -$224K 999
2023
Q1
$224K Sell
3,900
-9,210
-70% -$519K ﹤0.01% 917
2022
Q4
$735K Hold
13,110
0.01% 757
2022
Q3
$555K Hold
13,110
0.01% 800
2022
Q2
$708K Hold
13,110
0.01% 777
2022
Q1
$842K Hold
13,110
0.01% 792
2021
Q4
$879K Hold
13,110
0.01% 797
2021
Q3
$898K Sell
13,110
-600
-4% -$42.4K 0.01% 803
2021
Q2
$935K Hold
13,710
0.01% 801
2021
Q1
$948K Sell
13,710
-600
-4% -$40.6K 0.01% 784
2020
Q4
$929K Buy
14,310
+600
+4% +$32.3K 0.01% 761
2020
Q3
$647K Buy
13,710
+100
+0.7% +$4.76K 0.01% 790
2020
Q2
$640K Buy
13,610
+100
+0.7% +$4.92K 0.01% 778
2020
Q1
$603K Hold
13,510
0.01% 726
2019
Q4
$788K Hold
13,510
0.01% 798
2019
Q3
$811K Buy
13,510
+100
+0.7% +$5.96K 0.02% 780
2019
Q2
$749K Buy
13,410
+62
+0.5% +$3.19K 0.01% 819
2019
Q1
$744K Buy
13,348
+148
+1% +$7.54K 0.01% 823
2018
Q4
$595K Hold
13,200
0.01% 826
2018
Q3
$870K Sell
13,200
-200
-1% -$12.4K 0.02% 790
2018
Q2
$863K Buy
+13,400
New +$830K 0.02% 794

Other funds holding IART

Utah Retirement Systems's IART Position: Q2 2023 in Review

Utah Retirement Systems sold out of Integra LifeSciences (IART) in Q2 2023, closing a stake of 3,900 shares — an estimated $224K sold.

Utah Retirement Systems first reported a position in IART in Q2 2018 and held it in 20 quarters. The position peaked at $948K in Q1 2021. 283 funds tracked by Wall St. Rank hold IART as of Q2 2023.

  • Utah Retirement Systems reported no remaining Integra LifeSciences position as of Q2 2023 after selling out during the quarter.
  • Utah Retirement Systems sold 3,900 Integra LifeSciences shares in Q2 2023, an estimated $224K.
  • Utah Retirement Systems first reported a position in Integra LifeSciences in Q2 2018 and held it in 20 quarters.
  • Utah Retirement Systems's Integra LifeSciences position peaked at $948K in Q1 2021.
  • 283 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2023.

Based on Utah Retirement Systems's 13F filing for Q2 2023, filed 14 Aug 2023.